Resultados de procura - Jennifer Frueh
- Mostrando 1 - 3 Resultados de 3
-
1
Secukinumab demonstrates superiority over narrow‐band ultraviolet B phototherapy in new‐onset moderate to severe plaque psoriasis patients: Week 52 results from the <scp>STEPIn</sc... por Lars Iversen, Curdin Conrad, Liv Eidsmo, Antonio Costanzo, Joanna Narbutt, Andreas Pinter, Külli Kingo, R. Rivera, Frank Kolbinger, ManikPrabhu Nanna, Jennifer Frueh, Piotr Jagiello
Publicado 2023Artigo -
2
Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks por Esther von Stebut, Kristian Reich, Diamant Thaçi, Wolfgang Köenig, Andreas Pinter, Andreas Körber, Tienush Rassaf, Ari Waisman, Venkatesh Mani, Denise P. Yates, Jennifer Frueh, Christian Sieder, Nima Melzer, Nehal N. Mehta, Tommaso Gori
Publicado 2018Artigo -
3
Secukinumab treatment in new‐onset psoriasis: aiming to understand the potential for disease modification – rationale and design of the randomized, multicenter <scp>STEPI</scp>n st... por Lars Iversen, Liv Eidsmo, Joar Austad, Menno A. de Rie, Amra Osmančević, Lone Skov, T. Talme, Ingeborg Bachmann, Peter van de Kerkhof, Mona Ståhle, Rudrani Banerjee, Joseph B. Oliver, Andreas E. R. Fasth, Jennifer Frueh
Publicado 2018Artigo